Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine.
Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine.
复制标题
DOI:
10.3390/vaccines10091508
复制
发表时间:
2022-09-09
期刊:
影响因子:
7.8
通讯作者:
Kosten TA
中科院分区:
文献类型:
--
作者:
Haile CN;Varner KJ;Huijing X;Arora R;Orson FM;Kosten TR;Kosten TA
Background: Methamphetamine use disorder (MUD) is a growing health concern with no FDA-approved treatment. The present series of studies build upon our previous work developing an anti-methamphetamine (MA) vaccine for MUD. We determined the effects of a formulation that included tetanus-toxoid (TT) conjugated to succinyl-methamphetamine (TT-SMA) adsorbed onto aluminum hydroxide (alum) in combination with the novel Toll-Like Receptor-5 agonist, entolimod. Methods: Mice were vaccinated (0, 3, 6 weeks) with TT-SMA+alum and various doses of entolimod to determine an optimal dose for enhancing immunogenicity against MA. Functional effects were then assessed using MA-induced locomotor activation in mice. Experiments using passive immunization of antibodies generated by the vaccine tested its ability to attenuate MA-induced cardiovascular effects and alter the reinforcing effects of MA in an MA-induced reinstatement of a drug seeking model of relapse in male and female rats. Results: Antibody levels peaked at 10 weeks following vaccination with TT-SMA+alum combined with entolimod (1, 3 and 10 µg). MA-induced locomotor activation was significantly attenuated in vaccinated vs. unvaccinated mice and antibody levels significantly correlated with ambulation levels. Passive immunization decreased mean arterial pressure following MA dosing in rats of both sexes but did not alter heart rate. Passive immunization also attenuated the ability of MA to reinstate extinguished drug-seeking behavior in male and female rats. Results support further development of this vaccine for relapse prevention for individuals with MUD.
登录
查看更多内容
DOI:
10.1016/j.pbb.2010.12.004
发表时间:
2011-03
期刊:
Pharmacology, biochemistry, and behavior
影响因子:
--
作者:
Good RL;Radcliffe RA
通讯作者:
Radcliffe RA
影响因子:
7.3
作者:
Collins KC;Schlosburg JE;Bremer PT;Janda KD
通讯作者:
Janda KD
影响因子:
3.4
作者:
Kantak, KN;Collins, SL;Fox, BS
通讯作者:
Fox, BS
影响因子:
3.4
作者:
Keller, Courtney M.;Spence, Allyson L.;Goeder, Nicholas E. s
通讯作者:
Goeder, Nicholas E. s
DOI:
10.1039/c4cc00682h
发表时间:
2014-04-21
期刊:
Chemical communications (Cambridge, England)
影响因子:
--
作者:
Collins KC;Schlosburg JE;Lockner JW;Bremer PT;Ellis BA;Janda KD
通讯作者:
Janda KD